Infection with any of the rotaviruses. Specific infections include human infantile diarrhea, neonatal calf diarrhea, and epidemic diarrhea of infant mice.
Comprehensive, easy-to-understand information about this condition
How we create this content →Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 5, 2026
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning Rotavirus infection
Updated Sep 21, 2011
A CDC study reveals that rotavirus vaccination in infants significantly reduces healthcare costs and doctor visits related to diarrhea in young children. This underscores the economic benefits of vaccination programs in preventing rotavirus infections.
Research reveals new transmission patterns of rotavirus, which could inform vaccine strategies to prevent future epidemics. This discovery has the potential for significant global health impact, particularly in reducing childhood diarrhea-related morbidity.
This season has seen a decrease in rotavirus cases among children, potentially due to the introduction of a new infant vaccine. The CDC highlights the importance of vaccination in reducing the incidence of this viral infection.
The CDC reports that safety data for a newly licensed rotavirus vaccine shows intussusception cases fall within expected ranges, indicating no elevated risk. This finding supports the continued use of the vaccine in infants.